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ABSTRACT Sphingomyelin is an abundant component of eukaryotic membranes. A specific enzyme, sphingomyelinase can
convert this lipid to ceramide, a central second messenger in cellular signaling for apoptosis (programmed cell death),
differentiation, and senescence. We used microinjection and either Hoffman modulation contrast or fluorescence microscopy
of giant liposomes composed of 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (SOPC), N-palmitoyl-sphingomyelin (C16:
0-SM), and Bodipy-sphingomyelin as a fluorescent tracer (molar ratio 0.75:0.20:0.05, respectively) to observe changes in lipid
lateral distribution and membrane morphology upon formation of ceramide. Notably, in addition to rapid domain formation
(capping), vectorial budding of vesicles, i.e., endocytosis and shedding, can be induced by the asymmetrical sphingomyeli-
nase-catalyzed generation of ceramide in either the outer or the inner leaflet, respectively, of giant phosphatidylcholine/
sphingomyelin liposomes. These results are readily explained by 1) the lateral phase separation of ceramide enriched
domains, 2) the area difference between the adjacent monolayers, 3) the negative spontaneous curvature, and 4) the
augmented bending rigidity of the ceramide-containing domains, leading to membrane invagination and vesiculation of the
bilayer.
INTRODUCTION
Ceramide has recently been confirmed to function as a
second messenger in several cellular processes, including
apoptosis (programmed cell death), growth suppression,
differentiation, and cell senescence (for a review, see Han-
nun, 1996). Studies on ceramide-mediated cell signaling
cascades are focused on the search for its protein effectors;
however, only protein kinase C-, phospholipase A2, and
CAPP (ceramide-activated protein phosphatase) have been
demonstrated to be activated by this lipid in vitro (for a
review, see Hannun, 1996). In addition to its role in cell
signaling, ceramide has been suggested to enhance the for-
mation of atherosclerotic plagues (Kruth, 1997) and to be
responsible for retaining normal skin functions such as its
impermeability (Elias and Menon, 1991). As an amphi-
pathic molecule ceramide strongly favors partitioning into
bilayers, thus implying the possibility that changes in the
physical state of the membrane might be involved in cer-
amide-mediated cell functions. Therefore, an understanding
of the properties of ceramide-containing membranes is
needed to elucidate the roles of lipid-lipid and lipid-protein
interactions in determining the biological activities of this
lipid. To this end, it has been suggested that ceramide
causes packing defects in dipalmitoylphosphatidylcholine
(DPPC), resulting in an activation of phospholipase A2
(Huang et al., 1996).
In cellular membranes ceramide is formed upon the hy-
drolytic removal of the phosphocholine moiety of sphingo-
myelin by sphingomyelinase, and at least five sphingomy-
elinase species serving distinct functions have been
identified in eukaryotic cells (Liu et al., 1997). These en-
zymes are activated subsequent to the binding of extracel-
lular ligands to their plasma membrane receptors, as well as
by ionizing radiation, serum deprivation, and dexametha-
sone (Liu et al., 1997). At an early stage in apoptosis
activation of sphingomyelinase is observed (Jarvis et al.,
1996), and subjecting cells to the action of externally added
sphingomyelinase has been shown to cause apoptosis (Han-
nun and Obeid, 1995).
Sphingomyelin (SM) is a ubiquitous and abundant phos-
pholipid of eukaryote cells and in plasma membrane is
mainly present in the outer monolayer. Although the phys-
icochemical properties and thermal phase behavior of SM
are well known (Koynova and Caffrey, 1995), the signifi-
cance of this lipid to the structure and function of mem-
branes remains unidentified. SMs possess a high degree of
saturation, leading to considerably higher transition temper-
atures and higher microviscosity of the membranes com-
pared to phosphatidylcholines (Kolesnick, 1991). Interest-
ingly, the contents of phosphatidylcholines (PCs) and SMs
seem to be reciprocally controlled in cells, thus compensat-
ing the rigidifying effect caused by increased SM (Kole-
snick, 1991). Besides a structural role, SM also seems to be
involved in several cellular processes, such as viral fusion,
attachment of cells to the substrate, and, e.g., disorders such
as Niemann-Pick disease (Jwa Hidari et al., 1997; Nieva et
al., 1994; Merrill and Jones, 1990).
In contrast to SM, only a few studies have been made that
have been able to relate the physicochemical properties of
ceramide to its cellular effects. The thermotropic behavior
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of non-hydroxy- and -hydroxy fatty acid ceramides has
been resolved by differential scanning calorimetry and x-ray
diffraction (Shah et al., 1995a,b). The contents of ceramide
in the membranes of cells undergoing apoptosis may reach
10 mol% of the total phospholipid (Hannun, 1996). A
similar content of natural ceramides was required for the
formation of microdomains enriched in this lipid in vitro in
both the gel state and fluid large unilamellar vesicles
(LUVs) (Holopainen et al., 1997, 1998). Ceramide-enriched
microdomains also form upon generation of ceramide by
sphingomyelinase in vitro in PC/SM LUVs (Holopainen et
al., 1998). Accordingly, after the conversion of sphingomy-
elin to ceramide, the organization of the membrane no
longer corresponds to thermodynamic equilibrium, but the
membrane is in a metastable state. Subsequently, the latter
decays to a new steady state; the rate of this reorganization
process is diffusion controlled. As hydrophobic mismatch
(Holopainen et al., 1997) could be excluded as the cause of
lateral segregation of this lipid, this seems likely to arise
from the properties of the ceramide headgroup. Although
the exact mechanism remains somewhat uncertain, a feasi-
ble explanation is intermolecular hydrogen bonding, when
the chemical structure of ceramide is taken into account.
Compared to glycerophospholipids, which can act only as
acceptors of hydrogen bonds, sphingolipids such as sphin-
gomyelin and ceramide can act as both acceptors and donors
because of their hydroxyl and amino groups, respectively,
and because of the phosphate moiety of the former lipid
(Pascher, 1976). To this end, recent Fourier transform in-
frared (FTIR) spectroscopy provided detailed information
on acyl chain and headgroup inter- and intramolecular in-
teractions in non-hydroxy (NFA) and -hydroxy (HFA)
fatty acid ceramides and revealed strong intermolecular
hydrogen bonds, particularly for the former type (Moore et
al., 1997).
Alterations in plasma membrane morphology with shed-
ding of vesicles into the extracellular space is one of the
hallmarks of apoptosis (Majno and Joris, 1995). Yet the
possible relationship between changes in lipid composition
(formation of ceramide) and changes in membrane mor-
phology has not been investigated. Because of the remark-
able similarity of the characteristic morphological changes
in all cell lines studied, similar mechanisms have been
suggested to be responsible. The mechanism of budding of
the fluid-filled, structureless, and membrane-enclosed ves-
icles in apoptosis is not understood but is thought to arise
from the disconnection of the cell membrane and cytoskel-
eton (Majno and Joris, 1995). Investigation of processes
such as undulation, healing, and budding has become pos-
sible with the use of the so-called giant unilamellar vesicles
(Ø  50–500 m) (Menger and Keiper, 1998) and has
provided unprecedented insight into the mechanistic basis
of changes in vesicle morphology (Lipowsky, 1991; Seifert
and Lipowsky, 1996). In this study we used giant liposomes
and microinjection to explore the possibility that formation
of ceramide in membranes could also be involved in the
underlying mechanisms controlling cell morphology.
MATERIALS AND METHODS
Materials
C16:0-sphingomyelin was from Northern Lipids (Vancouver, BC, Can-
ada), and SOPC was from Avanti Polar Lipids (Alabaster, AL). The
concentration of Bodipy-sphingomyelin (Molecular Probes, Eugene, OR)
was determined spectrophotometrically, using 91,000 cm1 at 505 nm as
its molar extinction coefficient. Concentrations of the other lipids were
determined gravimetrically with a high-precision electrobalance (Cahn,
Cerritos, CA). The purity of the lipids was checked by thin-layer chroma-
tography on silicic acid-coated plates (Merck, Darmstadt, Germany) de-
veloped with chloroform/methanol/water (65:25:4, v/v/v). Examination of
the plates after iodine staining or, when appropriate, by fluorescence
illumination revealed no impurities. Pro analysis grade solvents were from
Merck, and other chemicals were from standard sources.
Liposome preparation
Lipid stock solutions (10 mM and 2.5 mM for SOPC and C16:0-
sphingomyelin, respectively) were mixed in chloroform to obtain the
desired composition, with Bodipy-sphingomyelin included as a fluorescent
probe (final molar ratio 0.75:0.20:0.05 for SOPC, C16:0-sphingomyelin,
and Bodipy-sphingomyelin, respectively). The solvent was evaporated
under a stream of nitrogen, and subsequent evacuation under reduced
pressure for at least 12 h. The dry residue was dissolved in diethylether:
methanol (9:1, v/v) to yield a final total lipid concentration of 1 mM.
Approximately one microliter of this solution was applied onto the surface
of each Pt electrode (Angelova and Dimitrov, 1986), which was then dried
with a stream of nitrogen and evacuation in vacuum for 1 h. A glass
chamber with the attached electrodes and a quartz window bottom was
placed on the stage of a Zeiss IM-35 inverted fluorescence microscope (see
instrument setup from Wick et al., 1996). An AC voltage of 0.2 V (f  4
Hz) was applied before 1.3 ml of 0.5 mM HEPES buffer (pH 7.4) was
added. During the first minute of hydration the voltage was raised to 1 V.
After 2 h the AC field was turned off, and giant liposomes were observed
with Hoffman modulation contrast optics with a (10) objective or by
epifluorescence with a Nikon ELWD (20) objective. The excitation and
emission wavelengths were selected with filters (Melles-Griot) transmit-
ting in the range of 420–480 nm and 500 nm, respectively. Images were
viewed with a Peltier-cooled digital camera (C4742-95; Hamamatsu, Ja-
pan) connected to a computer.
Microinjection of sphingomyelinase
Micropipettes with inner tip diameters of 0.5 m (Schnorf et al., 1994)
were made from borosilicate capillaries (1.2 mm outer diameter) by a
microprocessor-controlled horizontal puller (P-87; Sutter Instrument Co.,
Novato, CA). Picoliter aliquots of sphingomyelinase (sphingomyelin phos-
phodiesterase, EC 3.1.4.12, Bacillus cereus, from Sigma, 1 unit/ml, spe-
cific activity 100–300 units/mg protein in 9 mM CaCl2, 1.8 mM MgCl2
aqueous solution) were applied either to the outer surface or to the interior
of individual giant vesicles with a pneumatic microinjector (PLI-100;
Medical Systems Corp., Greenvale, NY). For easier handling only vesicles
attached to the electrode surface were used.
All experiments were repeated at least 15 times with excellent repro-
ducibility. Yet the lag time in the formation of domains after external
application of SMase varied to some extent (from 10 to 150 s). This
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variation is likely to be due to the varying distance of the micropipette tip
from the vesicle surface, allowing for the diffusion and uncontrolled
dilution of the enzyme into the medium.
RESULTS
We investigated the possibility that the apoptotic lipidic
messenger, ceramide, could be involved in causing changes
in the membrane morphology of cells undergoing apoptosis.
Giant liposomes composed of 1-stearoyl-2-oleoyl-sn-glyc-
ero-3-phosphocholine (SOPC) and N-palmitoyl-sphingomy-
elin (C16:0-SM) readily formed in an AC field and were
visualized by fluorescence microscopy of the included flu-
orescent lipid tracer (molar ratio 0.75:0.20:0.05 for SOPC,
C16:0-SM, and Bodipy-sphingomyelin, respectively) (Fig.
1 A). Uniform distribution of the fluorescent lipid
Bodipy-SM is evident at the resolution of the optical mi-
croscope, in keeping with the miscibility of sphingomyelin
in PC membranes (Calhoun and Shipley, 1979; McKeone et
al., 1986).
We have recently demonstrated by using large unilamel-
lar liposomes that in contrast to sphingomyelin, ceramide
forms microdomains in both fluid as well as in gel-state PC
FIGURE 1 Transformations of a single SOPC/C16:0-sphingomyelin/Bodipy-sphingomyelin (molar ratio 0.75:0.20:0.05) giant vesicle, induced by the
addition of Bacillus cereus sphingomyelinase in the vicinity of the vesicle. Still fluorescence images were taken (A) before enzyme administration and after
(B) 20 s, (C) 40 s, and (D) 2 min. The length of the scale bar in D corresponds to 100 m.
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membranes (Holopainen et al., 1997, 1998). To investigate
the consequences of enzymatic conversion of sphingomye-
lin to ceramide in a fluid lipid membrane, we treated the
above giant phosphatidylcholine/sphingomyelin vesicles by
sphingomyelinase. Within 30 s after the external applica-
tion of this enzyme to the vicinity of the outer membrane
surface, domains with increased fluorescence intensity be-
come observable (Fig. 1 B, arrow). The reason for their
diffuse appearance is likely to be their 3-D nature, so that
each domain is only partly in the focal plane. Likewise,
fairly long exposure times (0.5–2 s) had to be used in
fluorescence microscopy, thus resulting in Brownian mo-
tion, causing haziness of the domain appearance. Notably,
we did use a rather high probe concentration (X 0.05) and
did not want to increase this, so as to limit the membrane
perturbing effect of Bdp-sphingomyelin. The resolution fur-
ther suffers from the 3-D nature of the system. Subsequent
to their emergence, these membrane regions increase in
brightness (Fig. 1, C), and in 1–2 min the domains are
“endocytosed” as smaller vesicles into the interior of the
giant liposome (Fig. 1 D). The phase separation process was
quantitated by measurement of the loss of fluorescence
intensity of the probe at a distal part of the GUV (marked by
* in Fig. 1); this clearly shows the emission intensity to be
reduced in the membrane outside the fluorescence domains
(Fig. 2). A possible explanation for this is photobleaching of
the probe; however, on the time scale of our experiments
this was negligible. Moreover, the intensity is reduced by
30%, thus indicating that half of the Bodipy-sphingomy-
elin in the outer leaflet is contained in the formed microdo-
mains (either as such or as the corresponding ceramide). As
a further progression, when this process is viewed in real
time, the microdomains then increase in thickness toward
the interior. Subsequently, we see the appearance of small
fluorescent vesicles within the GUV, together with disap-
pearance of the domains on the GUV surface. To verify our
results indicating vesicle formation inside GUVs, we used
Hoffman modulation contrast optics, allowing for the use of
short exposure times (1 ms) (Fig. 3 A). In keeping with the
above fluorescence images, within 60 s a number of small
vesicles became observable (Fig. 3 B, arrow). A further
increase in time results in progressive accumulation of small
vesicles in the GUV interior (Fig. 3, C and D). The diameter
of these vesicles is quite constant (2.7 	 0.08 m). In this
case the newly formed small vesicles stay apart from each
other, whereas in Fig. 1 they are clustered. The reason for
this remains unknown but could be related to the amount of
ceramide in the vesicles. Interestingly, Alonso and co-work-
ers have shown that hydrolysis of SM/PE/cholesterol vesi-
cles by sphingomyelinase causes their aggregation/fusion
(Ruiz-Argu¨ello et al., 1996; Basa´n˜ez et al., 1997).
Notably, in the above experiment the formation of cer-
amide probably takes place only in the outer leaflet of the
giant liposome. The formation of ceramide in both leaflets
of the bilayers would require either 1) permeation of B.
cereus SMase through the bilayer and/or 2) rapid transbi-
layer diffusion of ceramide. We do not consider the first
mechanism to be feasible for an enzyme with a molecular
mass of 37 kDa. The second mechanism would require the
flip-flop rate of ceramide to be very fast. This is in contrast
to the halftime of 22 min for the spontaneous transbilayer
movement rates measured for the fluorescently labeled cer-
amide (Bai and Pagano, 1997). However, our previous work
showed that extensive degradation of sphingomyelin in
LUVs (average diameter of 100 nm) did exceed 50% (Ho-
lopainen et al., 1998). Taken together, it is possible that
ceramide could also transfer into the inner surface of GUVs.
It is very likely that external application of the enzyme
results in an asymmetry in bilayer lipid composition. It was
therefore of interest to investigate the consequences of
formation of ceramide in the inner leaflet of the giant
vesicle. For this purpose, sphingomyelinase was microin-
jected into the interior of the giant liposome (Fig. 4, A). As
in the formation of ceramide by externally applied sphin-
gomyelinase, within 30 s we observed the appearance of
diffuse fluorescent domains in the membrane (Fig. 4, B).
After 1–2 min small (Ø  5.0 	 0.17 m) liposomes
emerged on the outer surface of the giant liposome (Fig. 4,
C); their number continued to increase for several minutes
(Fig. 4, D). These vesicles eventually formed a layer on the
giant liposome surface and had a remarkably homogeneous
size distribution. Compared to the external addition of the
enzyme, the reaction seems to proceed for a longer time.
This difference could be explained by the externally added
enzyme becoming diluted into the bulk aqueous phase,
FIGURE 2 Time course for the decrease in the fluorescence intensity in
the bilayer after application of Bacillus cereus sphingomyelinase. The
intensity changes were measured at a place distal to the enzyme addition
(marked with * in Fig. 1).
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resulting in the attenuation of the local rate of ceramide
formation.
Perhaps, somewhat unexpectedly, the vesicle diameter
does not decrease, although vesiculation retracts lipids from
the GUV surface into the interior of the vesicle. For tech-
nical reasons vesicles that were not attached to the platinum
wire could not be used. Accordingly, the connection of the
vesicle to the lipid on the electrode is likely to provide the
source for the new lipid that is transferred into the giant
vesicle. The reasons for the lack of vesicle shrinkage are
likely to be the following. First, the phosphocholine head-
group released into the interior of the vesicle acts as an
osmolyte, causing water influx from outside of the GUV.
Second, it is possible that blebbing of vesicles is accompa-
nied by transient connection of the aqueous compartments
(Zhang et al., 1998).
DISCUSSION
The present study provides the first demonstration of vec-
torial formation of vesicles, i.e., endocytosis and budding,
to be induced by the asymmetrical formation of ceramide by
sphingomyelinase in either the outer or inner leaflet, respec-
tively, of giant liposomes. This is distinct from the previ-
ously reported effects of another lipolytic enzyme, phos-
FIGURE 3 Changes in the vesicle topology induced by the addition of sphingomyelinase in the vicinity of SOPC/C16:0-sphingomyelin/Bodipy-
sphingomyelin (molar ratio 0.75:0.20:0.05) giant vesicle. Still Hoffman modulation contrast microscopy images were taken (A) before enzyme adminis-
tration and after (B) 60 s, (C) 120 s, and (D) 180 s. The length of the scale bar in D corresponds to 20 m.
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pholipase A2. In brief, subjecting giant 1-palmitoyl-2-
oleoyl-phosphatidylcholine (POPC) liposomes to either the
external or internal action of phospholipase A2 causes these
vesicles to burst and shrink, respectively (Wick et al., 1996).
Importantly, these authors showed that vesicle morphology
is not altered by lysozyme, because protein has no enzy-
matic activity toward the bilayer.The formation of vesicles
from GUV is preceded by the rapid emergence of laterally
segregated domains enriched in the fluorescent marker.
The physical foundations of the determinants of vesicle
shapes are reasonably well established and have been laid in
terms of excess area in one of the leaflets of a bilayer (Farge
and Devaux, 1993), area-to-volume ratio (Do¨bereiner et al.,
1993), bending elasticity, and spontaneous curvature
(Evans, 1974; Gruner, 1989; Helfrich, 1973; Lipowsky,
1991, 1992; Sackmann, 1994; Seifert and Lipowsky, 1996).
Osmotically induced shape changes and fission of small
vesicles have been shown previously (for a review, see
Sackmann, 1994). Also lateral domain formation establish-
ing domain boundaries contributes to vesicle budding (Ju¨li-
cher and Lipowsky, 1993; Lipowsky, 1992; Seifert and
Lipowsky, 1996). The equilibrium shape for a multicompo-
FIGURE 4 Microinjection of sphingomyelinase into a single SOPC/C16:0-sphingomyelin/Bodipy-sphingomyelin (molar ratio 0.75:0.20:0.05) giant
vesicle. Still fluorescence images were recorded (A) before the enzyme addition and (B) 1 min, (C), 3 min, and (D) 10 min after the microinjection. The
length of the scale bar in D corresponds to 100 m.
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nent system is achieved at the free energy minimum for the
alloy, the relevant forces also including bending energy,
causing either mixing or lateral phase separation of the
individual components. Because of the coupling of curva-
ture and local enrichment of lipids, introducing two or more
components into the membrane results in a nonuniform
membrane and leads to nonzero spontaneous curvature.
Perhaps the simplest two-component system is represented
by the coexistence region in a membrane undergoing a
phase transition between fluid and gel phases. To this end,
upon increasing the temperature one can observe the pinch-
ing off of small vesicles (Ø  1 m) from bovine brain
sphingomyelin giant vesicles (Do¨bereiner et al., 1993). An
important conclusion from these data is that the dynamics
required for these processes to occur in living cells could be
inherent to the shape phase diagram of the lipid membranes,
thus making proteins unnecessary as the driving force (Do¨-
bereiner et al., 1993).
A model schematically delineating the present results is
illustrated in Fig. 5. In Fig. 5 A the lipids in the SOPC/SM
monolayer are randomly distributed. Hydrolytic cleavage of
the phosphocholine headgroup from SM by sphingomyeli-
nase generates ceramide, a lipid with a small, less hydrated
headgroup (Fig. 5 B). Compared to a typical phosphatidyl-
choline such as POPC with a mean molecular area of 70 Å2
(Feng and MacDonald, 1995), the area for ceramide in the
monolayer is small, 40 Å2 (Lo¨fgren and Pascher, 1977).
Accordingly, the leaflet containing ceramide condenses,
thus causing an area difference with respect to the adjacent
leaflet of the bilayer. Subsequently (Fig. 5 C), the formed
ceramide segregates into a domain; a likely driving force is
intermolecular hydrogen bonding (Pascher, 1976). Because
of the tendency of ceramide to form inverted nonlamellar
phases (Ruiz-Argu¨ello et al., 1996), an invagination is
formed by the ceramide-enriched domain (Fig. 5 D). The
driving force is thus provided by 1) the area difference
between the adjacent monolayers (Farge and Devaux,
1993), and 2) the negative spontaneous curvature for the
ceramide-containing domain (Ruiz-Argu¨ello et al., 1996;
Veiga et al., 1998). In addition, the bending rigidity of the
ceramide-enriched domain must exceed that of the adjacent
leaflet of the bilayer. The domain then grows in size and
finally forms an enclosed cavity (not shown). It should be
emphasized that although illustrated above as separate
events, the formation of ceramide, its local enrichment, and
membrane bending should all occur simultaneously.
In light of the present results demonstrating budding of
vesicles from giant liposomes after the microinjection of
sphingomyelinase into the vesicle interior, it seems reason-
able to suggest that the enzymatic formation of ceramide
may well cause the observed membrane blebbing in apo-
ptosis, in a manner not requiring metabolic energy. Our
results thus indicate a possible central role for sphingomy-
elinase in controlling 3-D ordering of cellular membranes.
Regarding apoptosis, the contents of ceramide in such cells
have been reported to be very high, 10% of the total lipid at
most (Hannun, 1996). As the precursor sphingomyelin is
not evenly distributed in different cellular membranes, it
seems reasonable to assume that the local concentration of
ceramide could well exceed 25 mol%. Bearing this in mind,
we note that one possibility is that not only does ceramide
function as a traditional “lipid second messenger,” but the
effects of this bioactive lipid could also involve changes in
the physical state of the plasma membrane.
In addition to cellular signaling mechanisms, vesicle bud-
ding and endocytosis are crucial in the membrane traffick-
ing and internalization of plasma low-density lipoprotein
(LDL), for instance. In the plasma membrane endocytosis
involves caveolae, 50–60-nm diameter invaginations (Par-
ton et al., 1994). These ceramide-enriched membrane do-
mains contain G-protein-coupled receptors, and a role in
signal transduction has also been suggested (Lisanti et al.,
1994). There is evidence that interleukin-1 binds to a
sphingomyelin-rich plasma membrane domain with the
characteristics of caveolae. Hormone binding was accom-
FIGURE 5 A schematic model for the mechanism of ceramide domain
formation and invagination in a leaflet of a PC/sphingomyelin liposome,
induced by the asymmetrical hydrolytic action of sphingomyelinase. For
the sake of clarity only the monolayer subject to the action of sphingomy-
elinase is illustrated. E, SOPC; f, sphingomyelin; F, ceramide.
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panied by the hydrolysis of sphingomyelin to yield cer-
amide, and ceramide production was concluded to be highly
compartmentalized in the cell surface (Liu and Anderson,
1995). Very recently it was shown that exogenous sphingo-
myelinase treatment of ATP-depleted macrophages and fi-
broblasts results within 10 min in the budding of numerous
vesicles from the plasma membrane into the inside of these
cells (Zha et al., 1998). These vesicles have a diameter of
0.4 m and lack any observable protein coating. Very
recently, it was demonstrated that exogenously incorporated
N-hexanoyl-sphingosine (C6-ceramide) induced time- and
dose-dependent formation of vesicles (diameter 2–10 m)
in the interior of fibroblasts (Li et al., 1999). Our data show
that except for sphingomyelinase, no proteins are necessary
for endocytosis but can readily occur in giant liposomes.
Evidence for the involvement of sphingomyelinase and
phosphatidylcholine-specific phospholipase C in the entry
of Neisseria gonorrhoeae, Staphylococcus aureus, and spe-
cies of mycobacteria into human cells has recently been
demonstrated (Grassme´ et al., 1997; Johansen et al., 1996;
Walev et al., 1996). This mode of endocytosis could be
mediated by the concerted hydrolytic action of sphingomy-
elinase/phospholipase C of the plasma membrane of the
infected cells in a manner similar to that described here.
Experiments assessing these issues are currently in progress
in our laboratory.
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